Trial intelligence / Profile preview

Analgesics for pain control during copper or levonorgestrel intrauterine device insertion

RBR-7phn8yvPhase 4Not yet recruiting

Sponsor
Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM
Start
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ketorolac, Metamizole sodium, hyoscine butylbromide and homatropine methylbromide (2 arms), sponsored by Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM. Planned start Nov 2023; status: not yet recruiting.

02

Drugs

ketorolacMetamizole sodiumhyoscine butylbromidehomatropine methylbromide

Beyond the preview

Go deeper on RBR-7phn8yv.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-7phn8yv.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call